Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. [electronic resource]
Producer: 20100426Description: 147-54 p. digitalISSN:- 1474-5488
- Adenocarcinoma -- drug therapy
- Androgen Antagonists -- adverse effects
- Autonomic Agents -- therapeutic use
- Cyclohexanols -- therapeutic use
- Cyproterone Acetate -- therapeutic use
- Double-Blind Method
- Gonadotropin-Releasing Hormone -- analogs & derivatives
- Hot Flashes -- chemically induced
- Humans
- Male
- Medroxyprogesterone Acetate -- therapeutic use
- Prospective Studies
- Prostatic Neoplasms -- drug therapy
- Treatment Outcome
- Venlafaxine Hydrochloride
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.